Sukhvir Wright
YOU?
Author Swipe
View article: MRI cortical thickness in paediatric auto-immune encephalitis and acute disseminated encephalomyelitis
MRI cortical thickness in paediatric auto-immune encephalitis and acute disseminated encephalomyelitis Open
Children with autoimmune encephalitis may be subject to local cortical thinning in the long term.
View article: Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy
Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy Open
PRLs are common in pediatric MS and are linked to greater lesion burden and gray matter atrophy. These findings suggest that PRLs are promising imaging biomarkers of more severe brain tissue damage although their ability to predict future …
View article: Entropy of the resting state cortex in epilepsy
Entropy of the resting state cortex in epilepsy Open
Background Epilepsy has long been conceptualised as a disorder in which aberrant brain dynamics extend beyond the epileptogenic zone. Evidence demonstrates that loss of entropy is a generic feature of pathological dynamics in the brain, in…
View article: Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models
Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models Open
View article: Pediatric MOG-Ab–Associated Encephalitis
Pediatric MOG-Ab–Associated Encephalitis Open
MOG-Ab should be tested in all patients with suspected encephalitis even in the context of initially normal brain MRI. Although exclusion of infections should be part of the diagnostic process of any child with encephalitis, in immunocompe…
View article: Impact of autoantibodies against myelin oligodendrocyte glycoprotein in paediatric acquired demyelinating disease: Intellectual functioning and academic performance
Impact of autoantibodies against myelin oligodendrocyte glycoprotein in paediatric acquired demyelinating disease: Intellectual functioning and academic performance Open
Paediatric acquired demyelinating syndromes (pADS) attack white matter pathways in the brain during an important period of development. Affected children can experience poor functional outcomes, including deficits in specific cognitive dom…
View article: Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent models
Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent models Open
Anti-contactin associated protein receptor 2 (CASPR2) encephalitis is a severe autoimmune encephalitis with a variable clinical phenotype including behavioral abnormalities, cognitive decline, epileptic seizures, peripheral nerve hyperexci…
View article: Myo-inositol and total NAA in the hippocampus are linked to CSF tau pathology in cognitively normal older adults
Myo-inositol and total NAA in the hippocampus are linked to CSF tau pathology in cognitively normal older adults Open
INTRODUCTION Understanding relationships between in vivo neurometabolic changes and Alzheimer’s disease (AD) pathology in the hippocampus, a region vulnerable to early changes in AD, will support early diagnosis. METHODS Two studies using …
View article: NORSE/FIRES: how can we advance our understanding of this devastating condition?
NORSE/FIRES: how can we advance our understanding of this devastating condition? Open
Introduction New onset refractory status epilepticus (NORSE) is a rare and devastating condition characterised by the sudden onset of refractory status epilepticus (RSE) without an identifiable acute or active structural, toxic, or metabol…
View article: Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes Open
The risk of relapse in non-MS ADS depends on initial diagnosis, and MOG-Ab positivity. Long-term difficulties are observed regardless of relapses and are determined by presenting phenotype.
View article: Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures <i>in vivo</i>
Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures <i>in vivo</i> Open
One striking clinical hallmark in patients with autoantibodies to leucine-rich glioma inactivated 1 (LGI1) is the very frequent focal seizure semiologies, including faciobrachial dystonic seizures (FBDS), in addition to the amnesia. Polycl…
View article: Linking brain networks to cognition with magnetoencephalography in paediatric autoimmune encephalitis
Linking brain networks to cognition with magnetoencephalography in paediatric autoimmune encephalitis Open
Paediatric autoimmune encephalitis (e.g., acute disseminated encephalomyelitis, N-methyl-D-aspartate receptor antibody encephalitis) is an inflammatory brain disease that causes cognitive deficits, psychiatric symptoms, seizures, MRI, and …
View article: Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study
Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study Open
Paediatric autoimmune encephalitis, including acute disseminated encephalomyelitis, are inflammatory brain diseases presenting with cognitive deficits, psychiatric symptoms, seizures, MRI and EEG abnormalities. Despite improvements in dise…
View article: Peripherally derived LGI1-reactive monoclonal antibodies cause epileptic seizures<i>in vivo</i>
Peripherally derived LGI1-reactive monoclonal antibodies cause epileptic seizures<i>in vivo</i> Open
One striking clinical hallmark in patients with autoantibodies to leucine-rich glioma inactivated 1 (LGI1) is the very frequent focal seizure semiologies, including faciobrachial dystonic seizures (FBDS), in addition to the amnesia. Polycl…
View article: Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study
Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study Open
Objectives To describe the clinical presentation, investigations, management, and disease course in pediatric autoimmune limbic encephalitis (LE). Methods In this retrospective observational study, from the UK Childhood Neuroinflammatory D…
View article: Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.
Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures. Open
Autoantibodies targeting the GABAA receptor (GABAAR) hallmark an autoimmune encephalitis presenting with frequent seizures and psychomotor abnormalities. Their pathogenic role is still not well-defined, given the common overlap with furthe…
View article: Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10‐year follow‐up surveillance study
Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10‐year follow‐up surveillance study Open
Aim To describe a 10‐year follow‐up of children (<16y) with acquired demyelinating syndromes (ADS) from a UK‐wide prospective surveillance study. Method Diagnoses were retrieved from the patients' records via the patients' paediatric or ad…
View article: Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis
Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis Open
View article: Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD)
Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD) Open
View article: Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom Open
OBJECTIVES: To compare the real-world effectiveness of newer disease-modifying therapies (DMTs) vs injectables in children with relapsing-remitting multiple sclerosis (RRMS). METHODS: In this retrospective, multicenter study, from the UK C…
View article: Encephalitis patient derived monoclonal GABA<sub>A</sub>receptor antibodies cause catatonia and epileptic seizures
Encephalitis patient derived monoclonal GABA<sub>A</sub>receptor antibodies cause catatonia and epileptic seizures Open
Autoantibodies targeting the GABA A receptor (GABA A R) hallmark an autoimmune encephalitis presenting with frequent seizures and psychomotor abnormalities. Their pathogenic role is still not well-defined, given the common overlap with fur…
View article: Use of disease-modifying therapies in pediatric relapsing remitting multiple sclerosis in the UK
Use of disease-modifying therapies in pediatric relapsing remitting multiple sclerosis in the UK Open
View article: <i>In vitro</i>characterisation and neurosteroid treatment of an N-Methyl-D-Aspartate receptor antibody-mediated seizure model
<i>In vitro</i>characterisation and neurosteroid treatment of an N-Methyl-D-Aspartate receptor antibody-mediated seizure model Open
Seizures are a prominent feature in N-Methyl-D-Aspartate receptor antibody (NMDAR-Ab) encephalitis, a distinct neuro-immunological disorder in which specific human autoantibodies bind and crosslink the surface of NMDAR proteins thereby cau…
View article: Abolishing spontaneous epileptiform activity in human brain tissue through AMPA receptor inhibition
Abolishing spontaneous epileptiform activity in human brain tissue through AMPA receptor inhibition Open
Objective The amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (AMPAR) is increasingly recognized as a therapeutic target in drug‐refractory pediatric epilepsy. Perampanel (PER) is a non‐competitive AMPAR antagonist, and pre‐cli…
View article: In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications
In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications Open
Over the last two decades, the discovery of antibodies directed against neuronal surface antigens (NSA-Abs) in patients with different forms of encephalitis has provided a basis for immunotherapies in previously undefined disorders. Nevert…
View article: Acquired neuromyotonia in children with <scp>CASPR</scp>2 and <scp>LGI</scp>1 antibodies
Acquired neuromyotonia in children with <span>CASPR</span>2 and <span>LGI</span>1 antibodies Open
Acquired neuromyotonia is a form of peripheral nerve hyperexcitability. In adults, pathogenic antibodies that target the extracellular domains of leucine‐rich glioma‐inactivated protein 1 ( LGI 1) and contactin‐associated protein‐like 2 ( …
View article: NMDA-receptor antibodies alter cortical microcircuit dynamics
NMDA-receptor antibodies alter cortical microcircuit dynamics Open
NMDA-receptor antibodies (NMDAR-Abs) cause an autoimmune encephalitis with a diverse range of EEG abnormalities. NMDAR-Abs are believed to disrupt receptor function, but how blocking this excitatory synaptic receptor can lead to paroxysmal…
View article: Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Open
Although commonly used to treat patients with multiple sclerosis, DMDs were not associated with clinical improvement in children with MOG-Ab-associated disease, whereas azathioprine, mycophenolate mofetil, rituximab, and particularly intra…
View article: NMDA-receptor antibodies alter cortical microcircuit dynamics
NMDA-receptor antibodies alter cortical microcircuit dynamics Open
NMDA-receptor antibodies (NMDAR-Ab) cause an autoimmune encephalitis with a diverse range of electroencephalographic (EEG) abnormalities. NMDAR-Ab are believed to disrupt receptor function, but how blocking this excitatory neurotransmitter…
View article: <i>N</i>‐methyl‐<scp>d</scp>‐aspartate (<scp>NMDA</scp>) receptor antibodies encephalitis mimicking an autistic regression
<i>N</i>‐methyl‐<span>d</span>‐aspartate (<span>NMDA</span>) receptor antibodies encephalitis mimicking an autistic regression Open
Expressive dysphasia and mutism are common clinical features in children and adults with N ‐methyl‐ d ‐aspartate receptor antibodies ( NMDAR ‐Ab) encephalitis, and are likely to result from NMDAR hypofunction. A prodromal loss of social an…